EBITDA $210M to $225M vs. $232.2M last year. Sees FY25 capex $65M-$70M. Maximize Your Portfolio with Data Driven Insights:Leverage ...

JonesResearch analyst Catherine Novack initiated coverage of ProQR Therapeutics (PRQR) with a Buy rating and $11 price target The firm says ...